Cardiovascular system medicine sales in Chile are anticipated to see steady growth over the next few years. The forecasted value rises consistently from 226.37 billion Chilean Pesos in 2024 to 266.55 billion Chilean Pesos in 2028. For context, this represents a year-on-year variation of approximately 4.5% from 2024 to 2025, and 4.2% from 2027 to 2028. Looking at the data cumulatively, the compounded annual growth rate (CAGR) indicates an average increase of around 4.2% per year over the five-year forecast period.
Looking ahead, key trends to watch for include the impact of new technological advancements in cardiovascular treatments, healthcare policy changes, and shifts in patient demographics. The aging population and rising prevalence of cardiovascular diseases are likely to continue driving demand for these medicines. Additionally, innovations in personalized medicine and increased health awareness might further influence market dynamics positively.
